500 patients67,039 observations150 daysLIVE

Emergent Cluster EC-03NEW

28 patients

Early response followed by GI deterioration and treatment discontinuation.

Emerges around
Day 48
Detectable by LIFE OS
Day 30
Median clinical recognition
Day 77
Potential lead time
47 days

Average trajectory of the cluster

mean of 28 trajectories · dashed = model expectation at baseline
solid = observed · dashed = predicted

Shared signals

  • baseline state S14
  • inflammatory profile (IL6 variant, low HRV)
  • GI instability from day ~30
  • nutritional decline
  • low Akkermansia / butyrate capacity
  • prior intervention pattern
Mean response
49
Mean GI score
57
Discontinuation risk
75%

Potential action

GI-04 appears associated with improved persistence among similar patients (+17% persistence, −31% symptom burden in synthetic history).

Members